Entities / Entity
Center for Biologics Evaluation and Research.
FDA research center
- Reports this week
- 0
- Active events
- 0
- Connections
- 14
What's happening
Reports per dayLast 90 days
90 days agoDrag either end to show only events that began in that periodToday
Earlier this month
No events began in the chosen period. Widen it, or reset.
Around Center for Biologics Evaluation and Research this week
News at the entities that move Center for Biologics Evaluation and Research most-
FDA StructuralGeneric medicine services are seeking approval for launch from the FDA.Moves Center for Biologics Evaluation and Research
-
Teleflex Shared contextTrump's pledge to unleash oil and gas benefits stocks, specifically impacting El Pollo Loco Holdings, Inc.Moves Center for Biologics Evaluation and Research
Connections
The 3 strongest of 14, analyzed from the reporting. The bars show how strongly a change on one side reaches the other.-
FDA Structural
CBER is a specialized research center that operates as a division under the authority of the FDA.
-
Marty Makary Structural
Marty Makary holds a permanent director role at the Center for Biologics Evaluation and Research.
-
Teleflex Shared context
CBER operates as a regulatory body within the market context of Teleflex.